The specific genomic profile of NECs across organs, almost always TP53 and often RB1 mutations, especially in SCLC (37, 84), also suggests fundamental differences between NETs and NECs and the necessary mechanisms for a convergent NEC phenotype. Here, TP53 is linked to small cell lung carcinoma.